Tetsuzo Tauchi - Concepedia

Author

Tetsuzo Tauchi

Tokyo Medical University

Also Known As

Naoto Takahashi, Shinichiro Okamoto, T Tauchi, T. TAUCHI, T. Tauchi, Tauchi, Tetsuzo TAUCHI, Tetsuzo Tauchi

240

Publications

4.4K

Citations

H-Index

Concepts

All Affiliations

Tokyo Medical University Nagoya University Keio University Saitama Medical University The University of Tokyo

About

Tetsuzo Tauchi is an author at Tokyo Medical University specializing in medicine, cell biology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	42	1.8K
2	Cell Biology	18	24	1.4K
3	Health Sciences	10	10	278
4	Natural Sciences	4	4	324
5	Biochemistry	1	1	146

Tetsuzo Tauchi

Publications

3.3K

Citations

H-Index

Page 1

	Year	Citations
Telomerase inhibition with a novel G-quadruplex-interactive agent, telomestatin: in vitro and in vivo studies in acute leukemia Tetsuzo Tauchi, Kazuo Shin‐ya, Goro Sashida, Oncogene Hematological MalignancyNovel G-quadruplex-interactive AgentMedicineMalignant Blood DisorderAnti-cancer Agent	2006	219
Activity of a novel G-quadruplex-interactive telomerase inhibitor, telomestatin (SOT-095), against human leukemia cells: involvement of ATM-dependent DNA damage response pathways Tetsuzo Tauchi, Kazuo Shin‐ya, Goro Sashida, Oncogene Genome InstabilityOncogenic AgentMolecular BiologyHuman Leukemia CellsAdult T-cell Leukemia-lymphoma	2003	203
The ubiquitously expressed Syp phosphatase interacts with c-kit and Grb2 in hematopoietic cells. Tetsuzo Tauchi, Guosheng Feng, Mark S. Marshall, Journal of Biological Chemistry Cellular PhysiologySteel FactorSignaling PathwayCell RegulationReceptor Tyrosine Kinase	1994	146
Involvement of SH2-containing Phosphotyrosine Phosphatase Syp in Erythropoietin Receptor Signal Transduction Pathways Tetsuzo Tauchi, Gen‐Sheng Feng, Randy Shen, Journal of Biological Chemistry	1995	145
Role of p21 RAS in p210 bcr-abl transformation of murine myeloid cells RA Mandanas, DS Leibowitz, Kamran Gharehbaghi, Blood	1993	143
The oral iron chelator deferasirox represses signaling through the mTOR in myeloid leukemia cells by enhancing expression of REDD1 Junko H. Ohyashiki, Chiaki Kobayashi, Ryoko Hamamura, Cancer Science Hematological MalignancySignal TransductionMyeloid Leukemia CellsMixed-phenotype Acute LeukemiaMalignant Blood Disorder	2009	133
Coupling between p210bcr-abl and Shc and Grb2 adaptor proteins in hematopoietic cells permits growth factor receptor-independent link to ras activation pathway. Tetsuzo Tauchi, H. Scott Boswell, D Leibowitz, The Journal of Experimental Medicine ImmunologyEnforced ExpressionSignaling PathwayCell RegulationReceptor Tyrosine Kinase	1994	133
Role of p21 RAS in p210 bcr-abl transformation of murine myeloid cells RA Mandanas, DS Leibowitz, Kamran Gharehbaghi, Blood	1993	133
A Member of Forkhead Transcription Factor FKHRL1 Is a Downstream Effector of STI571-induced Cell Cycle Arrest in BCR-ABL-expressing Cells Norio Komatsu, Tomoko Watanabe, Mie Uchida, Journal of Biological Chemistry	2003	130
Telomerase inhibition enhances apoptosis in human acute leukemia cells: possibility of antitelomerase therapy Akihiro Nakajima, Tetsuzo Tauchi, Goro Sashida, Leukemia Hematological MalignancyMedicineMalignant Blood DisorderApoptosisImmunology	2003	101

Page 1